Dow Jones

39,308.00

-0.06%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Decision Diagnostics Corporation (CE) (DECN)
Decision Diagnostics Corporation (CE) (DECN) News

Decision Diagnostics (CE) (DECN)

Decision Diagnostics Corporation (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:DECN

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
06/07/2020	14:16	InvestorsHub NewsWire	The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)	USOTC:DECN	Decision Diagnostics Corporation (CE)
04/03/2020	15:15	InvestorsHub NewsWire	DECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic Methodology	USOTC:DECN	Decision Diagnostics Corporation (CE)
09/05/2019	14:55	InvestorsHub NewsWire	DECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...	USOTC:DECN	Decision Diagnostics Corporation (CE)
04/04/2019	15:00	InvestorsHub NewsWire	DECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAY	USOTC:DECN	Decision Diagnostics Corporation (CE)
18/03/2019	20:35	Edgar (US Regulatory)	Withdrawal of Offering Statement Under Regulation a (1-a-w)	USOTC:DECN	Decision Diagnostics Corporation (CE)
25/02/2019	20:34	Edgar (US Regulatory)	Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)	USOTC:DECN	Decision Diagnostics Corporation (CE)
30/01/2019	15:00	InvestorsHub NewsWire	DECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THE	USOTC:DECN	Decision Diagnostics Corporation (CE)
17/01/2019	14:55	InvestorsHub NewsWire	DECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERS	USOTC:DECN	Decision Diagnostics Corporation (CE)
19/12/2018	15:03	InvestorsHub NewsWire	DECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)	USOTC:DECN	Decision Diagnostics Corporation (CE)
17/12/2018	14:55	InvestorsHub NewsWire	DECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLY	USOTC:DECN	Decision Diagnostics Corporation (CE)
11/12/2018	15:00	InvestorsHub NewsWire	DECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...	USOTC:DECN	Decision Diagnostics Corporation (CE)
04/12/2018	15:00	InvestorsHub NewsWire	DECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018	USOTC:DECN	Decision Diagnostics Corporation (CE)
27/11/2018	14:50	InvestorsHub NewsWire	DECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER"	USOTC:DECN	Decision Diagnostics Corporation (CE)
06/11/2018	14:55	InvestorsHub NewsWire	DECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIP	USOTC:DECN	Decision Diagnostics Corporation (CE)
30/10/2018	13:33	InvestorsHub NewsWire	DECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSON	USOTC:DECN	Decision Diagnostics Corporation (CE)
29/10/2018	14:15	InvestorsHub NewsWire	DECN TO COMMENT AND PROVIDE ATTACK PLAN AFTER RECENT COURT RULING	USOTC:DECN	Decision Diagnostics Corporation (CE)
13/09/2018	15:00	InvestorsHub NewsWire	DECN BOARD OF DIRECTORS IN FINAL REVIEW OF PRELIMINARY FINANCING AGREEMENT FOR $4.75 MILLION INVESTMENT	USOTC:DECN	Decision Diagnostics Corporation (CE)
06/09/2018	15:00	InvestorsHub NewsWire	DECN ANNOUNCES MAJOR STEP AHEAD WITH OFFERING STATEMENT	USOTC:DECN	Decision Diagnostics Corporation (CE)
01/08/2018	13:06	Edgar (US Regulatory)	Registration a Offering Under the Securities Act of 1933 (1-a)	USOTC:DECN	Decision Diagnostics Corporation (CE)
18/04/2018	14:51	InvestorsHub NewsWire	Decision Diagnostics (DECN) Contemplates Additional Legal Actions Against Longtime Adversary Johnson & Johnson (JNJ)	USOTC:DECN	Decision Diagnostics Corporation (CE)
27/03/2018	20:05	InvestorsHub NewsWire	DECISION DIAGNOSTICS DISCUSSES CULMINATION OF PATENT CASE AGAINST J&J BASED ON THE FEDERAL DOCTRINE OF EQUIVALENTS	USOTC:DECN	Decision Diagnostics Corporation (CE)
21/03/2018	13:40	InvestorsHub NewsWire	DECISION DIAGNOSTICS' PANACEA GENPRECIS! PRODUCT MOVES INTO PRE-PRODUCTION, 1ST ROUND CLINICAL TRIALS TO BEGIN IN THE ~30 DAYS	USOTC:DECN	Decision Diagnostics Corporation (CE)
13/03/2018	13:50	InvestorsHub NewsWire	Decision Diagnostics' Fundamental Genchoice! Test Strip Moves into Clinical Trials in Advance of 510K Filing with FDA	USOTC:DECN	Decision Diagnostics Corporation (CE)
03/01/2018	14:55	InvestorsHub NewsWire	DECN ANNOUNCES 2018 BUSINESS FOCUS -- NEW PRODUCTS, CONCLUSION TO J&J LITIGATION & NEW ADDITION OF HYBRID PRIVATE LABEL MODEL	USOTC:DECN	Decision Diagnostics Corporation (CE)
20/12/2017	15:15	InvestorsHub NewsWire	DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP	USOTC:DECN	Decision Diagnostics Corporation (CE)
20/12/2017	15:15	InvestorsHub NewsWire	DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP	USOTC:DECN	Decision Diagnostics Corporation (CE)
20/12/2017	15:15	InvestorsHub NewsWire	DECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIP	USOTC:DECN	Decision Diagnostics Corporation (CE)
14/12/2017	15:00	InvestorsHub NewsWire	DECN ANNOUNCES IT'S NEW GENACCORD!™, DIABETIC TEST STRIP WITH FIRST USE OF ITS GENPRECIS!™ FULL SPREAD ELECTRODE ...	USOTC:DECN	Decision Diagnostics Corporation (CE)
01/11/2017	14:15	InvestorsHub NewsWire	DECISION DIAGNOSTICS CORP. (DECN) OFFERS UPDATE ON LEGAL PROCEEDINGS, OUTCOMES, HISTORY & SYNOPSIS ON ITS STRATEGIC SUIT VS. ...	USOTC:DECN	Decision Diagnostics Corporation (CE)
18/10/2017	15:10	InvestorsHub NewsWire	DECISION DIAGNOSTICS CORP FURTHER DISCUSSES ITS PANACEA GENPRECIS!™ PRODUCT	USOTC:DECN	Decision Diagnostics Corporation (CE)